Search

Your search keyword '"Gallo, Antonio"' showing total 1,546 results

Search Constraints

Start Over You searched for: Author "Gallo, Antonio" Remove constraint Author: "Gallo, Antonio"
1,546 results on '"Gallo, Antonio"'

Search Results

2. Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis

9. SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose

14. Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study

15. Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries

17. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries

18. Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPN

20. Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS)

24. Age- and sex-based heterogeneity in coronary artery plaque presence and burden in familial hypercholesterolemia: A multi-national study

25. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

27. Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative

29. Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals’ perspective

30. Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

32. Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey

40. Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis

41. Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study

42. COVID-19 vaccines and attributable risk of neurological disorders: a multicentre, case-control study (COVIVAX)

43. Impact of Genetic Susceptibility on Multiple Sclerosis Immune Methylome (S17.006)

44. Covid-19 Outbreak in Italy: An Opportunity to Evaluate Extended Interval Dosing of Ocrelizumab in MS Patients (P2-6.010)

46. The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study

47. Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia

50. Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study

Catalog

Books, media, physical & digital resources